Exercise in regional breast cancer with neoadjuvant anthracycline-based chemotherapy with immune checkpoint-inhibition: study protocol for a prospective randomised controlled trial - Top-Institutions - MDSpire

Exercise in regional breast cancer with neoadjuvant anthracycline-based chemotherapy with immune checkpoint-inhibition: study protocol for a prospective randomised controlled trial

  • By

  • Elena Murr

  • Sabine Grill

  • Marion Kiechle

  • Anne Kraemer

  • Bernadine Madl

  • Simon Glowka

  • Bernhard Haller

  • Caterina Fiorentini

  • Emmanuel Adjej

  • Mark J Haykowsky

  • Martin Halle

  • Simon Wernhart

  • June 5, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Oncology

Original Source(s)

Exercise in regional breast cancer with neoadjuvant anthracycline-based chemotherapy with immune checkpoint-inhibition: study protocol for a prospective randomised controlled trial

  • by Elena Murr, Sabine Grill, Marion Kiechle, Anne Kraemer, Bernadine Madl, Simon Glowka, Bernhard Haller, Caterina Fiorentini, Emmanuel Adjej, Mark J Haykowsky, Martin Halle, Simon Wernhart

  • June 5, 2026

Related Content

Integrating In silico perturbation with multilayer omics to decode regulatory networks in cancer immunity: a new frontier in precision oncology

Multiple primary head and neck cancers: a scenario-based framework for diagnosis and modern multidisciplinary management

Epidemiology, outcomes of treatment, and survival of cervical cancer in Kazakhstan: a nationwide population-based study